Cite
HARVARD Citation
Verdoia, M. et al. (2021). Low hemoglobin predicts high‐platelet reactivity and major cardiovascular ischemic events at long‐term follow‐up among ACS patients receiving dual antiplatelet therapy with ticagrelor. Catheterization and cardiovascular interventions. 98 (7), pp. 1309-1316. [Online].